Monitor for potential follow-on selling or lack of insider buying ahead of next earnings. While the dollar amount is not highly material, coordinated C-suite selling may signal limited near-term upside in the stock at current levels.
INSM drugs
INSM drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 30 $153.32entry
- T+1 · 8mo ago +6.65%α +3.76% · $163.52
- T+5 · 7mo ago +6.33%α +2.03% · $163.03
- T+20 · 7mo ago −11.99%α −24.58% · $134.94
- T+60 · 5mo ago −31.86%α −48.35% · $104.47
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two C-suite executives at Insmed sold shares in the past week, generating $4.06 million in total proceeds. The sales were open-market transactions following derivative exercises, with no open-market buying observed. This insider selling represents a modest but notable outflow relative to the company's $35B market cap.
Key Financial Metrics
Key Facts
- Chief Operating Officer Roger Adsett sold 6,715 shares for $1.10M on April 1, 2026.
- Chief Legal Officer Michael Smith sold 19,638 shares for $2.96M on March 30, 2026.
- Both executives also exercised stock options, including non-cash transactions totaling $1.38M in value.
- Total open-market selling in the cluster: $4.06M over 7 days.
- Selling represents approximately 0.012% of Insmed's $35B market cap.
Financial Impact
$4.06 million in open-market insider selling over 7 days
Risk Factors
- Perception of insider pessimism despite routine nature of post-exercise selling
- Potential for negative market reaction if investors interpret sales as lack of confidence
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-INSM-1775246891949 |
Track record
24 reports on INSM
4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +31.86% at T+60 after the Mar 30, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $111.59 Now $122.88 +10.12% settles Nov 27
- Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $94.04 Now $122.88 +30.67% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 3/10 Entry $95.67 Now $122.88 +28.44% settles Nov 17
- Oct 5, 20266w ago 8-K Neutral 4/10 Entry $103.83 to $112.58 Now $122.88 +18.35% ▲ +8.43% +10.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 4/10 Entry $125.08 to $120.00 Now $122.88 −1.76% ▼ −4.06% −4.19% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $126.33 to $129.41 Now $122.88 −2.73% ▲ +2.44% +4.19% vs SPY
- Aug 6, 202614w ago 8-K Bullish 8/10 Entry $132.55 to $126.68 Now $122.88 −7.30% ▼ −4.43% −5.03% vs SPY
- Jul 24, 202616w ago Institutional Cluster Neutral 4/10 Entry $106.92 to $125.77 Now $122.88 +14.93% ▲ +17.63% +14.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers